Your browser doesn't support javascript.
loading
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer.
Zhang, Libin; Chen, Yanhui; Wang, Han; Xu, Zheyuan; Wang, Yang; Li, Sixing; Liu, Jun; Chen, Yun; Luo, Hongli; Wu, Lijia; Yang, Ying; Zhang, Henghui; Peng, Hao.
Afiliación
  • Zhang L; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Chen Y; Department of Medicine, Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
  • Wang H; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Xu Z; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Wang Y; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Li S; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Liu J; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Chen Y; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
  • Luo H; Department of Medicine, Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
  • Wu L; Department of Bioinformatics, Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
  • Yang Y; Department of Bioinformatics, Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
  • Zhang H; Biomedical Inovation Center, Beijing Shijitan Hospital, Capital Medical University; School of Oncology, Capital Medical University, Beijing, China.
  • Peng H; Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China phao9375@163.com.
J Immunother Cancer ; 9(6)2021 06.
Article en En | MEDLINE | ID: mdl-34140315
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article